SOURCE: Cambridge Healthtech Institute

January 03, 2008 12:38 ET

Clay Christensen to Be Lead Keynote at Cambridge Healthtech Institute's Molecular Medicine Tri-Conference

NEEDHAM, MA--(Marketwire - January 3, 2008) - Cambridge Healthtech Institute's (CHI) flagship event, the Molecular Medicine Tri-Conference (March 25-28, 2008) will feature "Best Selling Author" Clay Christensen as a Plenary Keynote.

Clay Christensen, best known for his study of innovation in commercial enterprises and his theory of disruptive technology, will present a Plenary Keynote address entitled "Diagnosing the Disease: Disruptive Innovation in Healthcare." He is scheduled to provide the opening presentation of the event on March 25, 2008 at the Moscone Convention Center in San Francisco, California

Keynote Summary:

In the absence of the ability to precisely define a disease, the care of patients is best undertaken by highly skilled professionals, whose intuition is based on deep experience. This describes the history of health care, and we call this the practice of intuitive medicine. Molecular biology holds the promise of transforming medical practice into a new phase that we call precision medicine. It promises to dramatically reduce cost and increase the predictable effectiveness of therapy.

Phillips Kuhl, President of Cambridge Healthtech Institute, said, "Clay Christensen is a true 'thought leader' and perfectly positioned to provide great insight into the technology rich area of Molecular Medicine. I personally look forward to hearing him present on this complex topic."

About the Molecular Medicine Tri-Conference

The Molecular Medicine Tri-Conference is the flagship of event of CHI's portfolio of 100+ events. Now in its Fifteenth year, the Molecular Medicine Tri-Conference is the most comprehensive discovery, diagnostic and development event worldwide. Last year's event had record-setting attendance that brought over 2500 delegates from over 40 countries. For questions about the Molecular Medicine Tri-Conference, call Cambridge Healthtech Institute at 781-972-5400; or visit

About Cambridge Healthtech Institute

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI's portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech's Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.

Contact Information

  • Press Inquiries Please Contact:
    Tracey Fielding
    Cambridge Healthtech Institute
    Ph. (781) 972-5429
    Email Contact